Bempedoic acid improves outcomes in statin-intolerant patients
The cholesterol-lowering drug bempedoic acid reduced the combined rate of major adverse cardiovascular events by 13%, meeting its primary endpoint in a large study of patients with high cholesterol who were unable to tolerate ...
Mar 6, 2023
0
36